Endari is a prescription medication that has been approved by the FDA for the treatment of sickle cell disease in patients five years of age and older. This medication is specifically designed to help reduce the frequency of pain crises in individuals with sickle cell disease, a genetic blood disorder that causes red blood cells to become misshapen and sticky, leading to blockages in blood vessels and severe pain.

Endari works by increasing the production of a molecule called glutathione, which helps to protect red blood cells from damage and improve their function. By doing so, Endari can help to reduce the number of pain crises experienced by patients with sickle cell disease, as well as decrease the need for hospitalizations and other medical interventions.

It is important to note that Endari is not a cure for sickle cell disease, but rather a treatment option that can help to manage the symptoms of the condition and improve quality of life for patients. As with any medication, it is important to follow your healthcare provider’s instructions carefully and report any side effects or concerns that you may have while taking Endari.

Overall, Endari has been shown to be a safe and effective treatment option for individuals with sickle cell disease, and can help to reduce the impact of this chronic condition on daily life. If you or a loved one has been diagnosed with sickle cell disease, talk to your healthcare provider about whether Endari may be a suitable treatment option for you.